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   ndodontic infections are mixed aerobic-anaerobic infections and several microbial groups associated to these pathologies
are also involved in orofacial infections. The goal of this study was to evaluate the susceptibility of microorganisms isolated
from endodontic infections to β-lactams and metronidazole and verify the production of β-lactamases. Clinical specimens were
collected from 58 endodontic infections of 52 patients. The microorganisms were isolated in selective and non-selective culture
media, under anaerobiosis and aerobiosis, and identified using biochemical methods. In the susceptibility tests, it was used an
agar dilution method, and Wilkins-Chalgren agar enriched with blood, hemin and menadione for the anaerobes, while Mueller-
Hinton agar was employed for the facultative anaerobes. The production of β-lactamases was evaluated through the biological
and chromogenic cephalosporin methods. All tested isolates were sensitive to imipenem and 99.3% to amoxicillin/clavulanate
association, while 16.1% showed resistance to amoxicillin and penicillin G, and 4.89% to cefoxitin. Resistance to metronidazole
was just found in facultative anaerobes. Production of β-lactamases was detected in 18.2% of the isolates and presented a
correlation with resistance to β-lactams.
Uniterms: Infection; Antibacterial agents; β-lactams.
INTRODUCTION
Endodontic infections are mixed aerobic-anaerobic
infections characterized by a correlation between the virulence
of specific microorganisms and the host’s immune system23. In
the pathogenesis of these infections, specific microbial groups
play a relevant role, particularly strict tive anaerobes, which are
also associated to their clinical symptomatology 8,10. Such mixed
infections may afford an optimum situation for the exchange of
genetic elements between bacterial species.
The clinical outcome of endodontic treatment depends on
controlling the microbial biofilm that is established inside the
root canal system by means of instrumentation and antibacterial
irrigation. However, residual microorganisms in the root canals
are frequently involved in orofacial infections25. In the treatment
of these infections, systemic antibiotics can be prescribed to
prevent the spread of infection and onset of serious
complications3. However, empirical prescription of
antimicrobials as part of endodontic management is problematic,
given the diversity of potential pathogens and their different
sensitivity drugs.
The determination of in vitro antimicrobial susceptibility
may be important in certain situations, for example, to monitor
patterns of susceptibility and resistance in the population and
to aid in the selection of an appropriate antibiotic when
indicated in the endodontic treatment17. Moreover
susceptibility tests for anaerobes are not routine in Brazil.
Therefore, the objective of this study was to evaluate the
susceptibility of bacteria isolated from endodontic infections
to β-lactams and metronidazole and evaluate the production of
β-lactamases.
MATERIAL AND METHODS
This study was approved by the Ethics in Human Research
Committee of the Dental School of Araçatuba (FOA 01638).
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Patients
The population of this study consisted of 33 patients,
presenting at the Dental School of Araçatuba of São Paulo
State University (UNESP), and 19 patients attending private
clinics for endodontic treatment. Medical histories revealed
that all patients were in good general health. Patient ages ranged
from 19 to 61 years (mean age = 31.5). At the first visit, written
informed consent was obtained from each patient before
enrolment in the study. Patients who had received antibiotics 3
months before the root canal therapy and teeth with a
periodontal pocket probing depth greater than 4 mm were
excluded.
Clinical Signs and Symptoms
It was recorded the presence of carious tissue, pulp status,
presence and clinical conditions of restorations, pain on
occlusion, tenderness to percussion or palpation, swelling and
presence of periapical radiolucency, mobility, periodontal pocket
probing depth, presence of a sinus of endodontic origin,
intracanal condition, such as a dry canal or the presence of
exudates10. The diagnosis of endodontic pathology was
performed as described by Sigurdsson26.
Clinical Samples
The specimens were taken from 58 endodontic infections
of 52 patients. Clinical samples were collected from 32 teeth
with chronic endodontic infection, 10 teeth presenting acute
endodontic infection with acute periapical abscess and from
16 teeth presenting exacerbated periapical lesions and pulpal
necrosis. After anesthesia, a rubber dam was placed. The
operative field was disinfected and antisepsis of tooth enamel
was performed10. Access to the root canal system was gained
with sterile burs. In addition, sterile saline delivered through a
manual irrigation to avoid contamination from dental unit
waterlines. After removal of carious dentin, canal patency was
established with minimal instrumentation and without use of
any chemically active irrigant. Thereafter, the canal was soaked
with VMGAIII transport solution and clinical specimens were
collected by using sterile paper points, which were introduced
into the full canal length, as previously determined with a
preoperative radiograph. The paper points were kept in place
for 30-60 seconds and were transferred to VMGA III.
In the laboratory, aliquots of VMGA III were submitted to
serial 10 fold dilutions and were plated on Fastidious Anaerobic
Agar (FAA) supplemented with yeast extract (0.5%), hemin (5
µg/mL), menadione (1 µg/mL) and 5% horse blood, crystal
violet erythromicin agar (CVEA), FAA + nalixidic acid (0.001%
w/v) + vancomycin (0.5mg/L) and 5% horse blood, FAA +
vancomycin (0.5 mg/L) and kanamycin (0.016 mg/L), and
incubated under anaerobiosis (90% N2 + 10% CO2), at 37
oC, for
14, 04, 04 and 14 days, respectively11. The same dilutions were
plated on horse blood Brain Heart Infusion Agar and on
MacConkey agar, incubated aerobically, at 37oC for 2 days.
Pure cultures were obtained and the isolates were subjected
to morphocellular and morphocolonial analyses, respiratory
test and catalase assay. This was followed by identification of
the isolates at the genus level and, whenever possible, at the
species level, using commercial kits10 (BioMérieux SA, Marcy-
l‘Etoile, France) and carbohydrate fermentation.
Microorganisms
A total of 119 isolates of strict and facultative anaerobic
bacteria were subjected to the susceptibility tests. The bacterial
inocula were standardized in 105 cells and transferred to the
Petri plates containing the antimicrobials and the control plates
(without drugs), using a Steer’s replicator (Cefar Ltda, São Paulo,
SP, Brazil). The minimum inhibitory concentration (MIC) was
defined as the smallest concentration of the drug able to
completely inhibit the bacterial growth.
F. nucleatum ATCC 10953 and ATCC 25586, E. lentum ATCC
43055, and B. fragilis ATCC 23745 were used as reference strains
for quality control in the assays involving strict anaerobes,
while E. coli ATCC 25922, S. aureus ATCC 29213, P. aeruginosa
ATCC 27853, and E. faecalis ATCC 29212 were used in the
assays involving facultative anaerobes. The test and control
dishes were incubated anaerobically (90% N2 + 10% CO2) or
aerobically at 37ºC, for 48 hours.
Antimicrobial susceptibility tests
The following antimicrobial drugs were tested: amoxicillin
(Bayer S.A., São Paulo, SP, Brazil), amoxicillin/clavulanic acid
(Smithkline Beecham Brasil Ltda, São Paulo, SP, Brazil), cefoxitin
(Merck Sharp & Dohme, São Paulo, SP, Brazil), imipenem (Merck
Sharp & Dohme, São Paulo, SP, Brazil), benzylpenicillin
(Fontoura-Wyeth S.A., São Paulo, Brazil) and metronidazole
(Laboratórios Pfizer Ltda, Guarulhos, SP, Brazil). The breakpoints
used for interpretation were generally those recommended by
the NCCLS20. Antimicrobials were tested in concentrations that
ranged from 0.06 µg/mL to 512 µg/mL. The tests were carried
out by agar dilution method. Wilkins-Chalgren agar
supplemented with horse blood, hemin (5 µg/mL) and
menadione (1 µg/mL) was used for strict anaerobes and
Mueller-Hinton agar was used for facultative anaerobes.
Detection of β-lactamases
All microorganisms able to resist at least 0.5 µg/mL of any
of the tested β-lactms were submitted to tests to evaluate the
production of β-lactamases, using biological24 and chromogenic
cephalosporin methods6. These two methods were performed
because nitrocefin-based β-lactamase assays have not proven
useful in detecting β-lactamase production by some anaerobes6.
A chromogenic cephalosporin β-lactamase assay using
Cefinase disks was performed according to the manufacturer’s
instructions. Briefly, 6-mm-diameter filter paper disks
impregnated with nitrocefin were moistened with 0.85% NaCl,
and several isolated colonies of test organisms were transferred
to the disk. Disks were examined for the appearance of a pink-
red coloration for up to 10-60 min6.
In the biological method24, 20 µL of cultures of the resistant
isolate were plated on the surface of Wilkins-Chalgren agar,
containing 0.5µg/mL of the tested â-lactam. These plates were
then incubated anaerobically or aerobically at 37°C for 48 h.
After this incubation period, the cultures were exposed to
chloroform fumes for 20 min. and then covered with 3 mL of
semi-solid brain heart infusion (BHI) agar (0.7% agar) previously
inoculated with 106 cells of Streptococcus pyogenes FOA-94F14
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sensitive to all tested β-lactams in a concentration of ≤0.06 µg/
mL. The Petri dishes were then incubated under aerobiosis for
24 h at 37°C. After incubation, presence or absence of growth
of the streptococcal strain was checked. The presence of this
halo of growth was indicative of the degradation of the β-
lactam. Bacteroides fragilis ATCC 43858 was used as the
positive control of â-lactamase production.
RESULTS
Susceptibility to antimicrobial agents was evaluated on two
isolates of Actinomyces naeslundii, four isolates of A. israelii,
one isolate of A. odontolyticus,  two isolates of Actinomyces
sp., four Bacteroides sp., three isolates of Eubacterium sp.,
one isolate of E. lentum, five Enterococcus faecalis and
Fusobacterium sp., twelve F. nucleatum and
Peptostreptococcus sp., three P. anaerobius, two P.
asaccharolyticus,  four isolates of P. micros, three
Porphyromonas gingivalis, five Prevotella sp., ten isolates P.
intermedia-nigrescens, seven Propionibacterium sp., three
Proteus sp. and Selenomonas sp., nineteen isolates of
Streptococcus spp., four Staphylococcus epidermidis, and five
isolates of Veillonella sp.
The data presented in Table 1 show that imipenem was the
most effective β-lactam, while variable levels of microbial
resistance were observed for all other drugs. The association
amoxicillin/clavulanic acid was effective against all isolates but
one strain of Proteus sp., which produced β-lactamases active
on amoxicillin, penicillin G, and cefoxitin and was not inhibited
by clavulanic acid. Resistance to β-lactams was high among
the Gram-negative anaerobes, such as Prevotella intermedia-
nigrescens group and Veillonella sp. Resistance to
metronidazole was confined to facultative anaerobes, although
some Gram-positive strict anaerobes of genera
Peptostreptococcus and Bacteroides presented an intermediate
susceptibility.
Resistance to benzylpenicillin and amoxicillin varied among
the clinical strains, but most values of minimal inhibitory
concentrations were closely related and showed the same
pattern of â-lactamase production. Strains able to hydrolyze
penicillin G were able to perform amoxicillin degradation. Ten
(62.5%) out of sixteen isolates resistant to benzylpenicillin and
amoxicillin were β-lactamase producers, while all strains
resistant to cefoxitin were able to produce these hydrolytic
enzymes.
β-lactamase detection using biological and nitrocefin
methods provided the same results, which are presented in
Table 2. There was a correlation between resistance to β-lactams
and production of β-lactamases, which were active on penicillins
and cephalosporins. Figure 1 presents the data referring to
microbial resistance to β-lactams and β-lactamase production.
There was a close correlation between resistance to β-lactams
and production of β-lactamases. In strict anaerobes, 70% of all
isolates resistant to β-lactams were β-lactamase producers, while
80% of all facultative isolates resistant to these drugs also
produced such enzymes.
FIGURE 1- Resistance of strict and facultative anaerobes to β-lactams and production of β-lactamases
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Isolate (tested number) and
antimicrobials
Actinomyces spp. (9)
benzylpenicillin
amoxicillin
amoxicillin/clavulanic acid
cefoxitin
imipenem
metronidazole
Bacteroides sp. (4)
benzylpenicillin
amoxicillin
amoxicillin/clavulanic acid
cefoxitin
imipenem
metronidazole
Eubacterium spp. (4)
benzylpenicillin
amoxicillin
amoxicillin/clavulanic acid
cefoxitin
imipenem
metronidazole
Enterococcus faecalis (5)
benzylpenicillin
amoxicillin
amoxicillin/clavulanic acid
cefoxitin
imipenem
metronidazole
Fusobacterium spp. (17)
benzylpenicillin
amoxicillin
amoxicillin/clavulanic acid
cefoxitin
imipenem
metronidazole
Peptostreptococcus spp. (21)
benzylpenicillin
amoxicillin
amoxicillin/clavulanic acid
cefoxitin
imipenem
metronidazole
Porphyromonas gingivalis (3)
benzylpenicillin
amoxicillin
amoxicillin/clavulanic acid
cefoxitin
imipenem
metronidazole
%
1S 2I 3R
66.67 22.22 11.11
66.67 22.22 11.11
100 0.0 0.0
100 0.0 0.0
100 0.0 0.0
66.67 33.33 0.0
75 0.0 25
75 0.0 25
100 0.0 0.0
75 0.0 25
100 0.0 0.0
100 0.0 0.0
100 0 0
100 0 0
100 0 0
100 0 0
100 0.0 0.0
100 0.0 0.0
80 0.0 20
80 0.0 20
100 0.0 0.0
80 0.0 20
100 0.0 0.0
0.0 0.0 100
70.59 11.76 17.65
70.59 11.76 17.65
100 0.0 0.0
100 0.0 0.0
100 0.0 0.0
100 0.0 0.0
85.72 9.52 4.76
90.48 4.76 4.76
100 0.0 0.0
100 0.0 0.0
100 0.0 0.0
90.48 9.52 0.0
100 0 0
100 0 0
100 0 0
100 0 0
100 0 0
100 0 0
MIC(µg/mL)
Range 4MIC50 5MIC90
≤0.006-32 0.125 32
≤0.006-32 0.125 32
≤0.006-0.25 ≤0.006 0.25
≤0.006-0.5 ≤0.006 0.5
≤0.006-0.25 ≤0.006 0.25
≤0.006-16 0.5 16
≤0.006-256 0.25 256
≤0.006-128 0.25 128
≤0.006-1 0.25 1.0
≤0.006-32 0.125 32
≤0.006-8 0.125 8
≤0.006-16 0.125 16
≤0.006-0.5 ≤0.006 0.5
≤0.006-0.25 ≤0.006 0.25
≤0.006-0.25 ≤0.006 0.25
≤0.006-0.5 ≤0.006 0.5
≤0.006-0.5 ≤0.006 0.125
≤0.006-1 ≤0.006 1
≤0.006-128 ≤0.006 128
≤0.006-128 0.125 128
≤0.006-0.5 ≤0.006 0.5
≤0.006-128 ≤0.006 128
≤0.006-2 0.125 2
32->512 128 >512
≤0.006-256 0.125 8
≤0.006-256 0.125 8
≤0.006-0.5 ≤0.006 0.5
≤0.006-8 ≤0.006 4
≤0.006-0.5 ≤0.006 0.5
≤0.006-0.5 ≤0.006 0.5
≤0.006-16 ≤0.006 0.5
≤0.006-16 ≤0.006 0.5
≤0.006-0.5 ≤0.006 0.5
≤0.006-2 ≤0.006 1
≤0.006-0.5 ≤0.006 0.5
≤0.006-16 0.125 2.0
≤0.006-0.5 ≤0.006 0.5
≤0.006-0.25 ≤0.006 0.25
≤0.006-0.25 ≤0.006 0.25
≤0.006-0.5 ≤0.006 0.5
≤0.006-0.25 ≤0.006 0.25
≤0.006-0.25 ≤0.006 0.25
TABLE 1- Resistance of 119 clinical isolates isolated from endodontic infections to metronidazole and β-lactams
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Prevotella spp. (15)
benzylpenicillin
amoxicillin
amoxicillin/clavulanic acid
cefoxitin
imipenem
metronidazole
Propionibacterium sp. (7)
benzylpenicillin
amoxicillin
amoxicillin/clavulanic acid
cefoxitin
imipenem
metronidazole
Proteus sp. (3)
benzylpenicillin
amoxicillin
amoxicillin/clavulanic acid
cefoxitin
imipenem
metronidazole
Selenomonas sp. (3)
benzylpenicillin
amoxicillin
amoxicillin/clavulanic acid
cefoxitin
imipenem
metronidazole
Streptococcus spp. (19)
benzylpenicillin
amoxicillin
amoxicillin/clavulanic acid
cefoxitin
imipenem
metronidazole
Staphylococcus epidermidis (4)
benzylpenicillin
amoxicillin
amoxicillin/clavulanic acid
cefoxitin
imipenem
metronidazole
Veillonella sp. (5)
benzylpenicillin
amoxicillin
amoxicillin/clavulanic acid
cefoxitin
imipenem
metronidazole
60 20 20
66.67 13.33 20
93.33 6.67 0.0
80 13.34 6.67
100 0 0
100 0 0
85.71 14.28 0.0
85.71 14.28 0.0
100 0.0 0.0
100 0.0 0.0
100 0.0 0.0
57.14 48.86 0.0
0.0 33.33 66.67
0.0 33.33 66.67
0.0 66.67 33.33
0.0 33.33 66.67
66.67 33.33 0.0
0.0 0.0 100
100 0 0
100 0 0
100 0 0
100 0 0
100 0 0
100 0 0
84.21 10.52 5.26
89.48 5.26 5.26
100 5.26 0
89.47 10.52 0
100 0 0
21.06 10.52 68.42
0,0 50 50
0,0 50 50
50 50 0,0
75 25
75 25 0,0
0,0 0,0 100
60 20 20
60 20 20
100 0 0
100 0 0
100 0 0
100 0 0
≤0.006-512 0.25 128
≤0.006-256 0.25 128
≤0.006-2 0.125 2
≤0.006-128 0.5 32
≤0.006-1 ≤0.006 1
≤0.006-0.5 ≤0.006 0.5
≤0.006-16 ≤0.006 1
≤0.006-16 0.125 1
≤0.006-0.5 ≤0.006 0.5
≤0.006-2 ≤0.006 1
≤0.006-0.5 ≤0.006 0.5
≤0.006-16 2 16
1-256 64 256
1-256 64 256
4-32 4 32
32-256 128 256
2-8 2 8
>512 >512 >512
≤0.006-0.5 ≤0.006 0.5
≤0.006-0.25 ≤0.006 0.25
≤0.006-0.25 ≤0.006 0.25
≤0.006-0.5 ≤0.006 0.5
≤0.006-0.25 ≤0.006 0.25
≤0.006-0.25 ≤0.006 0.25
≤0.006-16 ≤0.006 1
≤0.006-16 ≤0.006 1
≤0.006-0.25 ≤0.006 0.25
≤0.006-32 0.25 32
≤0.006-0.25 ≤0.006 0.25
1->512 ≤0.006 128
1->512 1 >512
1->512 1 >512
0.5-2 0.5 2
2-128 2 128
0.5-2 0.5 2
256->512 >512 >512
≤0.006-16 0.25 1
≤0.006-16 0.25 1
≤0.006-0.25 ≤0.006 0.25
≤0.006-0.5 ≤0.006 0.5
≤0.006-0.25 ≤0.006 0.25
≤0.006-0.25 ≤0.006 0.25
Cont.Table 1
1Susceptible
2Intermediate
3Resistant
4Minimal Inhibitory Concentration for 50% of the isolates
5Minimal Inhibitory Concentration for 90% of the isolates
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DISCUSSION
Most studies that deal with the emergence of antimicrobial
resistance of oral bacteria have been done in the western world
and little information is available from developing countries1,
which have socioeconomic and behavioral factors that promote
bacterial resistance22, such as self-prescription and misuse.
The resistance of strict and facultative anaerobic
microorganisms has expanded considerably2,27, which has
rendered traditional prescription habits critical in the absence
of laboratorial exams. This fact is further aggravated when one
considers the relevance of the phenomenon of self-medication
in Brazil, which limits the efficacy of treatment and can make
prescribing a difficult task, as it modifies the local patterns of
susceptibility to drugs.
The use of antimicrobial drugs may constitute an important
adjuvant in the treatment of endodontic and periapical
infections, particularly in acute cases16, but it sometimes comes
up against the problem of selection of microorganisms resistant
to the most frequently used drugs. Moreover, this resistance is
usually manifested by the production of enzymes that are able
to degrade these drugs19, and anaerobic genera, such as
Fusobacterium and Prevotella, are generally the main
producers of these enzymes14,15,21, but they are highly sensitive
to metronidazole1. The results listed in Table 1 are in accordance
with these concepts, as resistance to most â-lactams seems to
be frequently found in some genera, such as Prevotella and
Fusobacterium and facultative rods and cocci.
The resistance to amoxicillin and penicillin G was
significantly higher than previously reported in the literature
concerning anaerobes from oral samples retrieved in developed
countries7,18,27, but the data were in accordance with data from
developing countries1,3. Regarding the most frequently isolated
facultative bacteria, genus Streptococcus, the resistance to β-
lactams are slightly more elevated than those previously
reported4,5. Thus, the bacteria that accounted for the
significantly increased proportion of resistance to amoxicillin
and penicillin G in clinical samples were Gram-negative rods
that inhabit periodontal pockets and gingival crevice7,9.
As the combination of amoxicillin/clavulanic acid was
effective on almost all the isolates resistant to the other β-
lactams (except for one isolate of Proteus sp.), as previously
observed2,11,13,19, it could be suggested that the mechanism of
resistance to these drugs occurred due to the production of
inactivating enzymes, although the action of some β-lactamases
is not inhibited by addition of clavulanic acid13,18. In anaerobic
Gram-negative bacteria, these β-lactamases are active on
penicillins and cephalosporins27, as in accordance with the
data presented in Table 2.  On the other hand, the efficiency of
imipenem on these bacteria highlights the need to leave the
carbapenems for exclusive use in serious infections to avoid
the dissemination of resistance.
The data shown in Table 1 substantiated the idea that
clavulanic acid, a β-lactam devoid of antimicrobial activity but
able to inhibit the action of an extensive group of enzymes that
inactivate these drugs, and its associations with other β-
lactams, may constitute an important option for prescription,
particularly when the patient has a previous history of use of
drugs of this group in the 2-3 preceding months.
In anaerobic Gram-negative bacteria, these β-lactamases
are active on penicillins and cephalosporins27, as in accordance
with the data presented in Table 2. Moreover, some isolates of
genus Bacteroides and facultative anaerobes were resistant to
amoxicillin, penicillin G and cefoxitin, the use of cephalosporins
in substitution of penicillins in the treatment of serious mixed
infections is compromised, especially in patients with history
of previous use of penicillins. On the other hand, the efficiency
of imipenem on these bacteria highlights the need to leave the
carbapenems for use exclusively in serious infections to avoid
the dissemination of resistance.
Some isolates that are resistant to β-lactams were proved
not to be producers of β-lactamase by the methodology
employed in this study (Table 2). This suggests that these
bacteria are producers of non-exportable β-lactamases, as
previously reported in Gram-negative bacteria12, or the existence
of other mechanism of microbial resistance, such as alteration
of structure of penicillin-binding proteins reducing the affinity
to the β-lactams, or the method’s sensitivity did not allow for
the detection of these enzymes.
Microorganisms Resistant isolates/ resistant isolates producers of β-lactamases
Amoxicillin Cefoxitin Penicillin
Actinomyces spp. 1/0 0/0 1/0
Bacteroides sp. 1/1 1/1 1/1
E. faecalis 1/1 1/1 1/1
Fusobacterium spp. 3/2 0/0 3/2
Peptostreptococcus spp. 1/0 0/0 1/0
Prevotella spp. 3/3 1/1 3/3
Proteus sp. 2/1 1/1 2/1
Streptococcus spp. 1/1 0/0 1/1
S. epidermidis 2/1 0,0 2/1
Veillonella sp. 1/0 0/0 1/0
Total 16/10 4/4 16/10
TABLE 2- Production of β-lactamases by resistant microorganisms isolated from endodontic infections
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CONCLUSIONS
The results of the present study indicate that, among the
tested microorganisms, resistance to β-lactams was not
disseminated and was more frequently found in some Gram-
negative anaerobic rods, enteric microorganisms and facultative
cocci. The resistance to these drugs was closely related to the
production of β-lactamases. Resistance to metronidazole was
observed only in facultative anaerobes.
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